Published in Brain Res on April 18, 1997
PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases. Nat Med (2013) 1.96
Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J Virol (2002) 1.59
Measuring prions by bioluminescence imaging. Proc Natl Acad Sci U S A (2009) 1.59
The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.55
Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J Virol (2000) 1.34
Glutamate-mediated cytosolic calcium oscillations regulate a pulsatile prostaglandin release from cultured rat astrocytes. J Physiol (2003) 1.27
Identification of upregulated genes in scrapie-infected brain tissue. J Virol (2000) 1.23
Microglial activation varies in different models of Creutzfeldt-Jakob disease. J Virol (1999) 1.13
Role of interleukin-1 in prion disease-associated astrocyte activation. Am J Pathol (2004) 1.13
Accelerated prion disease in the absence of interleukin-10. J Virol (2004) 1.10
Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains. J Virol (2006) 1.05
Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels. J Virol (2009) 1.03
Brain infection by neuroinvasive but avirulent murine oncornaviruses. J Virol (2000) 0.94
Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice. J Virol (2008) 0.92
Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration. Mol Neurodegener (2010) 0.92
Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression. J Neuroimmunol (2008) 0.91
The interpretation of disease phenotypes to identify TSE strains in mice: characterisation of BSE using PrPSc distribution patterns in the brain. Vet Res (2012) 0.82
Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines. PLoS One (2009) 0.82
Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction. J Virol (2014) 0.82
IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: localization, partial characterization, and expression. Mamm Genome (2007) 0.78
Prion pathogenesis in the absence of NLRP3/ASC inflammasomes. PLoS One (2015) 0.77
Inhibition of cytosolic Phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin. BMC Neurosci (2012) 0.76
Intracerebral administration of interleukin-12 (IL-12) and IL-18 modifies the course of mouse scrapie. BMC Vet Res (2006) 0.76
Amphotericin B induces glial cell line-derived neurotrophic factor in the rat brain. J Vet Med Sci (2014) 0.75
Pathogenic prion protein fragment (PrP106-126) promotes human immunodeficiency virus type-1 infection in peripheral blood monocyte-derived macrophages. Virology (2015) 0.75
Synthetic prion Peptide 106-126 resulted in an increase matrix metalloproteinases and inflammatory cytokines from rat astrocytes and microglial cells. Toxicol Res (2012) 0.75
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
The prevalence of hypertension in seven populations of west African origin. Am J Public Health (1997) 5.55
Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group". J Clin Microbiol (1990) 4.03
The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol (1968) 3.60
The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol (1991) 3.47
Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J Comp Pathol (1968) 3.31
N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility. Nat Cell Biol (2001) 2.91
Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci (1994) 2.76
The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. J Gen Virol (1989) 2.64
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia (2009) 2.50
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart (2006) 2.33
Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Pathol (1973) 2.28
Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat Med (1999) 2.14
Serum inflammatory proteins and cognitive decline in older persons. Neurology (2005) 2.11
The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol (2005) 2.05
Standardization of blood pressure measurement in an international comparative study. J Clin Epidemiol (1996) 1.99
Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun (2007) 1.98
Transmission of bovine spongiform encephalopathy to sheep and goats. Vet Rec (1993) 1.97
Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol (1982) 1.93
The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. Br J Cancer (2010) 1.91
Molecular composition of mitochondrial ATP-sensitive potassium channels probed by viral Kir gene transfer. J Mol Cell Cardiol (2000) 1.88
PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice. J Pathol (1992) 1.79
Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry (1990) 1.74
Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases. Neuroreport (1999) 1.68
Scrapie strain variation and its implications. Curr Top Microbiol Immunol (1991) 1.65
A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol (1989) 1.62
The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol (1993) 1.60
Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J Biol Chem (2001) 1.59
Pathogenesis of scrapie in the mouse: the role of the spleen. Nature (1970) 1.58
Planning treatment of ischemic heart disease with partially observable Markov decision processes. Artif Intell Med (2000) 1.56
The colposuspension operation for urinary incontinence. Br J Obstet Gynaecol (1976) 1.51
Competition between different scrapie agents in mice. Nat New Biol (1972) 1.48
Dementia and mortality in persons with Down's syndrome. J Intellect Disabil Res (2006) 1.48
Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J Comp Pathol (1978) 1.47
Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.46
Focal modification of electrical conduction in the heart by viral gene transfer. Nat Med (2000) 1.45
Protothecosis in hematopoietic stem cell transplantation: case report and review of previous cases. Transpl Infect Dis (2014) 1.43
Neuronal spread of scrapie agent and targeting of lesions within the retino-tectal pathway. Nature (1982) 1.41
Phillips report and the origin of BSE. Vet Rec (2000) 1.39
[The immune system and Alzheimer's disease]. Tijdschr Psychiatr (2011) 1.38
Conjunctival instillation of scrapie in mice can produce disease. Vet Microbiol (1993) 1.36
Prevalence of NIDDM among populations of the African diaspora. Diabetes Care (1997) 1.36
PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol (1997) 1.35
Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol (2001) 1.30
Relationship of internalized racism to abdominal obesity and blood pressure in Afro-Caribbean women. J Natl Med Assoc (1999) 1.29
Genetical control of the concentration of ME7 scrapie agent in the brain of mice. J Comp Pathol (1969) 1.28
Scrapie in the central nervous system: neuroanatomical spread of infection and Sinc control of pathogenesis. J Gen Virol (1992) 1.28
Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. Int J Dev Neurosci (2005) 1.26
Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol (2004) 1.26
Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry (1993) 1.25
Characterization of non-lymphoid cells in the white pulp of the mouse spleen: an in vivo and in vitro study. Cell Tissue Res (1978) 1.25
Detection of BSE infectivity in brain and spleen of experimentally infected sheep. Vet Rec (1996) 1.24
Scrapie incubation time can exceed natural lifespan. Nature (1975) 1.24
Infectious etiology of neuritic (senile) plaques in mice. Science (1975) 1.23
Focal seizures and non-ketotic hyperglycaemia. J Neurol Neurosurg Psychiatry (1992) 1.22
Argyrophilic plaques in mice inoculated with scrapie from particular sources. Lancet (1973) 1.20
Extraneural competition between different scrapie agents leading to loss of infectivity. Nature (1975) 1.20
Distribution of experimentally induced scrapie lesions in the brain. Nature (1967) 1.20
Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci Lett (1989) 1.17
Clinical and urodynamic features of failed incontinence surgery in the female. Obstet Gynecol (1978) 1.16
Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol (1994) 1.15
Effect of route of infection on the frequency and distribution of cerebral amyloid plaques in scrapie mice. Neuropathol Appl Neurobiol (1981) 1.15
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. Leukemia (2010) 1.15
Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol Dis (2000) 1.14
Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 1.14
Characterization of the microglial response in murine scrapie. Neuropathol Appl Neurobiol (1994) 1.12
Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease. J Epidemiol Community Health (1993) 1.12
Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology. Curr Pharm Des (2008) 1.12
Scrapie infection can be established readily through skin scarification in immunocompetent but not immunodeficient mice. J Gen Virol (1996) 1.11
Modeling treatment of ischemic heart disease with partially observable Markov decision processes. Proc AMIA Symp (1998) 1.11
Targeting of scrapie lesions and spread of agent via the retino-tectal projection. Brain Res (1985) 1.10
Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ Res (2001) 1.08
Preparation of growth hormone free from contamination with unconventional slow viruses. Lancet (1985) 1.08
Archie Cochrane's challenge: can periodically updated reviews of all randomised controlled trials relevant to neurology and neurosurgery be produced? J Neurol Neurosurg Psychiatry (1994) 1.08
Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Am J Pathol (1993) 1.07
Inheritance of BSE. Vet Rec (1990) 1.07
Ultrastructural features of spongiform encephalopathy transmitted to mice from three species of bovidae. Acta Neuropathol (1992) 1.07
Expression of interleukin-1 beta in rat dorsal root ganglia. J Neuroimmunol (2001) 1.06
Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy. Brain Behav Immun (2008) 1.05
Microglia, amyloid and dementia in alzheimer disease. A correlative study. Neurobiol Aging (2000) 1.05
Eosinophilic bodies in some neurones in the thalamus of ageing mice. J Pathol (1969) 1.04
Degenerative hippocampal pathology in mice infected with scrapie. Acta Neuropathol (1984) 1.03
Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS. Am J Physiol (1997) 1.03
Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience (1999) 1.02
Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol (1999) 1.02
Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res (1994) 1.02
Characterization of lymphoid and nonlymphoid cells in the white pulp of the spleen using immunohistoperoxidase techniques and enzyme-histochemistry. Experientia (1985) 1.01
Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur Cytokine Netw (1998) 1.01
The pathology of a natural and experimental scrapie. Front Biol (1976) 1.01
NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2. Brain Res (1997) 1.01
Immunostaining of scrapie cerebral amyloid plaques with antisera raised to scrapie-associated fibrils (SAF). Neuropathol Appl Neurobiol (1989) 1.00
Detection of apoptosis in murine scrapie. Neurosci Lett (1995) 1.00
Severely combined immunodeficient (SCID) mice resist infection with bovine spongiform encephalopathy. J Gen Virol (1997) 1.00
Genetical control of the concentration of ME7 scrapie agent in mouse spleen. J Comp Pathol (1969) 0.98